Crossmark

Authors’ Reply to Lechat et al.: “Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?”

Published Online: 2019-08-27

Published Print: 2019-10

Authors

Concordet, Didier

Gandia, Peggy

Montastruc, Jean-Louis

Bousquet-Mélou, Alain

Lees, Peter

Ferran, Aude A.

Toutain, Pierre-Louis https://orcid.org/0000-0002-8846-8892
License Information

Text and Data Mining valid from 2019-08-27

Version of Record valid from 2019-08-27
More Information

Article History

First Online: 27 August 2019

Compliance with Ethical Standards

:

: No sources of funding were used in the preparation of this reply.

: Didier Concordet, Peggy Gandia, Jean-Louis Montastruc, Alain Bousquet-Mélou, Peter Lees, Aude A. Ferran, and Pierre-Louis Toutain have no conflicts of interest that are directly relevant to the content of this reply.

Document is current